Profitable Year For Samsung Biologics For Its Continuous Stable Business Performance
Samsung Biologics has established itself as a leading CDMO and one of the most impactful biopharmaceutical companies in the world. Just halfway through 2021, they’ve already made numerous groundbreaking decisions